United States Nuclear Medicine-Radiopharmaceuticals Market Report 2016

November 2016 | 109 pages | ID: UB33285745EEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Nuclear Medicine-Radiopharmaceuticals

Revenue, means the sales value of Nuclear Medicine-Radiopharmaceuticals

This report studies sales (consumption) of Nuclear Medicine-Radiopharmaceuticals in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Cardinal Health, Inc (US)
• GE Healthcare (UK)
• Bracco Imaging S.p.A (Italy)
• Nordion, Inc. (Canada)
• Bayer HealthCare Medical Care (US)
• Lantheus Medical Imaging Inc (US)
• Advanced Medical Isotope Corporation (US)
• Alliance Medical (UK)
• Alseres Pharmaceuticals, Inc (US)
• Avid Radiopharmaceuticals (US)
• Actinium Pharmaceuticals Inc (US)
• Ion Beam Applications S.A (Belgium)
• Immunomedics, Inc. (US)
• Jubilant Pharma (India)
• Mallinckrodt Pharmaceuticals (Ireland)
• Medi-Radiopharma Ltd (Hungary)
• Peregrine Pharmaceuticals, Inc. (US)
• Siemens Healthcare (US)
• Positron Corporation (US)
• Triad Isotopes, Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
• Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Nuclear Medicine-Radiopharmaceuticals in each application, can be divided into

• Diagnostic Applications: SPECT, PET.
• Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
• Application 3

Contents

United States Nuclear Medicine-Radiopharmaceuticals Market Report 2016

1 NUCLEAR MEDICINE-RADIOPHARMACEUTICALS OVERVIEW

1.1 Product Overview and Scope of Nuclear Medicine-Radiopharmaceuticals
1.2 Classification of Nuclear Medicine-Radiopharmaceuticals
  1.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
  1.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
  1.2.3 Type III
1.3 Application of Nuclear Medicine-Radiopharmaceuticals
  1.3.1 Diagnostic Applications: SPECT, PET.
  1.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Nuclear Medicine-Radiopharmaceuticals (2011-2021)
  1.4.1 United States Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2021)
  1.4.2 United States Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)

2 UNITED STATES NUCLEAR MEDICINE-RADIOPHARMACEUTICALS COMPETITION BY MANUFACTURERS

2.1 United States Nuclear Medicine-Radiopharmaceuticals Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Nuclear Medicine-Radiopharmaceuticals Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Nuclear Medicine-Radiopharmaceuticals Average Price by Manufactures (2015 and 2016)
2.4 Nuclear Medicine-Radiopharmaceuticals Market Competitive Situation and Trends
  2.4.1 Nuclear Medicine-Radiopharmaceuticals Market Concentration Rate
  2.4.2 Nuclear Medicine-Radiopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NUCLEAR MEDICINE-RADIOPHARMACEUTICALS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Type (2011-2016)
3.2 United States Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2011-2016)
3.3 United States Nuclear Medicine-Radiopharmaceuticals Price by Type (2011-2016)
3.4 United States Nuclear Medicine-Radiopharmaceuticals Sales Growth Rate by Type (2011-2016)

4 UNITED STATES NUCLEAR MEDICINE-RADIOPHARMACEUTICALS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Application (2011-2016)
4.2 United States Nuclear Medicine-Radiopharmaceuticals Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES NUCLEAR MEDICINE-RADIOPHARMACEUTICALS MANUFACTURERS PROFILES/ANALYSIS

5.1 Cardinal Health, Inc (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 GE Healthcare (UK)
  5.2.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Bracco Imaging S.p.A (Italy)
  5.3.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Nordion, Inc. (Canada)
  5.4.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Bayer HealthCare Medical Care (US)
  5.5.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Lantheus Medical Imaging Inc (US)
  5.6.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Advanced Medical Isotope Corporation (US)
  5.7.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Alliance Medical (UK)
  5.8.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Alseres Pharmaceuticals, Inc (US)
  5.9.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Avid Radiopharmaceuticals (US)
  5.10.2 Nuclear Medicine-Radiopharmaceuticals Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Actinium Pharmaceuticals Inc (US)
5.12 Ion Beam Applications S.A (Belgium)
5.13 Immunomedics, Inc. (US)
5.14 Jubilant Pharma (India)
5.15 Mallinckrodt Pharmaceuticals (Ireland)
5.16 Medi-Radiopharma Ltd (Hungary)
5.17 Peregrine Pharmaceuticals, Inc. (US)
5.18 Siemens Healthcare (US)
5.19 Positron Corporation (US)
5.20 Triad Isotopes, Inc. (US)

6 NUCLEAR MEDICINE-RADIOPHARMACEUTICALS MANUFACTURING COST ANALYSIS

6.1 Nuclear Medicine-Radiopharmaceuticals Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Nuclear Medicine-Radiopharmaceuticals

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Nuclear Medicine-Radiopharmaceuticals Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES NUCLEAR MEDICINE-RADIOPHARMACEUTICALS MARKET FORECAST (2016-2021)

10.1 United States Nuclear Medicine-Radiopharmaceuticals Sales, Revenue Forecast (2016-2021)
10.2 United States Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Type (2016-2021)
10.3 United States Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Application (2016-2021)
10.4 Nuclear Medicine-Radiopharmaceuticals Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nuclear Medicine-Radiopharmaceuticals
Table Classification of Nuclear Medicine-Radiopharmaceuticals
Figure United States Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Type in 2015
Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Picture
Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Picture
Table Application of Nuclear Medicine-Radiopharmaceuticals
Figure United States Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Application in 2015
Figure Diagnostic Applications: SPECT, PET. Examples
Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Examples
Figure United States Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2011-2021)
Figure United States Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2011-2021)
Table United States Nuclear Medicine-Radiopharmaceuticals Sales of Key Manufacturers (2015 and 2016)
Table United States Nuclear Medicine-Radiopharmaceuticals Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nuclear Medicine-Radiopharmaceuticals Sales Share by Manufacturers
Figure 2016 Nuclear Medicine-Radiopharmaceuticals Sales Share by Manufacturers
Table United States Nuclear Medicine-Radiopharmaceuticals Revenue by Manufacturers (2015 and 2016)
Table United States Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers
Table 2016 United States Nuclear Medicine-Radiopharmaceuticals Revenue Share by Manufacturers
Table United States Market Nuclear Medicine-Radiopharmaceuticals Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Nuclear Medicine-Radiopharmaceuticals Average Price of Key Manufacturers in 2015
Figure Nuclear Medicine-Radiopharmaceuticals Market Share of Top 3 Manufacturers
Figure Nuclear Medicine-Radiopharmaceuticals Market Share of Top 5 Manufacturers
Table United States Nuclear Medicine-Radiopharmaceuticals Sales by Type (2011-2016)
Table United States Nuclear Medicine-Radiopharmaceuticals Sales Share by Type (2011-2016)
Figure United States Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Type in 2015
Table United States Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2011-2016)
Table United States Nuclear Medicine-Radiopharmaceuticals Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Nuclear Medicine-Radiopharmaceuticals by Type (2011-2016)
Table United States Nuclear Medicine-Radiopharmaceuticals Price by Type (2011-2016)
Figure United States Nuclear Medicine-Radiopharmaceuticals Sales Growth Rate by Type (2011-2016)
Table United States Nuclear Medicine-Radiopharmaceuticals Sales by Application (2011-2016)
Table United States Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Application (2011-2016)
Figure United States Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Application in 2015
Table United States Nuclear Medicine-Radiopharmaceuticals Sales Growth Rate by Application (2011-2016)
Figure United States Nuclear Medicine-Radiopharmaceuticals Sales Growth Rate by Application (2011-2016)
Table Cardinal Health, Inc (US) Basic Information List
Table Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table GE Healthcare (UK) Basic Information List
Table GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Bracco Imaging S.p.A (Italy) Basic Information List
Table Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Nordion, Inc. (Canada) Basic Information List
Table Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Bayer HealthCare Medical Care (US) Basic Information List
Table Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Lantheus Medical Imaging Inc (US) Basic Information List
Table Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Advanced Medical Isotope Corporation (US) Basic Information List
Table Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Alliance Medical (UK) Basic Information List
Table Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Alseres Pharmaceuticals, Inc (US) Basic Information List
Table Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Avid Radiopharmaceuticals (US) Basic Information List
Table Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Actinium Pharmaceuticals Inc (US) Basic Information List
Table Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Ion Beam Applications S.A (Belgium) Basic Information List
Table Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Immunomedics, Inc. (US) Basic Information List
Table Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Jubilant Pharma (India) Basic Information List
Table Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Mallinckrodt Pharmaceuticals (Ireland) Basic Information List
Table Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Medi-Radiopharma Ltd (Hungary) Basic Information List
Table Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Peregrine Pharmaceuticals, Inc. (US) Basic Information List
Table Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Siemens Healthcare (US) Basic Information List
Table Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Positron Corporation (US) Basic Information List
Table Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Triad Isotopes, Inc. (US) Basic Information List
Table Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals
Figure Manufacturing Process Analysis of Nuclear Medicine-Radiopharmaceuticals
Figure Nuclear Medicine-Radiopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015
Table Major Buyers of Nuclear Medicine-Radiopharmaceuticals
Table Distributors/Traders List
Figure United States Nuclear Medicine-Radiopharmaceuticals Production and Growth Rate Forecast (2016-2021)
Figure United States Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Table United States Nuclear Medicine-Radiopharmaceuticals Production Forecast by Type (2016-2021)
Table United States Nuclear Medicine-Radiopharmaceuticals Consumption Forecast by Application (2016-2021)